GC3110A Quadrivalent Influenza Vaccine

GC3110A · Green Cross Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GC3110A Quadrivalent Influenza Vaccine, covering 2014-08-13 to 2014-08-13. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/IIa Study of GC3110A (Quadrivalent Influenza Vaccine) [Phase 1, Phase 2]